Immunogenicity and efficacy evaluation of subunit astrovirus vaccines

Mehdi R.M. Bidokhti, Karin Ullman, Anne Sofie Hammer, Trine Hammer Jensen, Mariann Chriél, Siddappa N. Byrareddy, Claudia Baule

Research output: Contribution to journalArticle

Abstract

A full understanding of the immune response to astrovirus (AstV) infection is required to treat and control AstV-induced gastroenteritis. Relative contributions of each arm of the immune system in restricting AstV infection remain unknown. In this study, two novel subunit AstV vaccines derived from capsid protein (CP) of mink AstV (MAstV) such as CP∆N (spanning amino acids 161–775) and CP∆C (spanning amino acids 1–621) were evaluated. Their immunogenicity and cytokine production in mice, as well as protective efficacy in mink litters via maternal immunization, were studied. Truncated CPs induced higher levels of serum anti-CP antibodies than CP, with the highest level for CP∆N. No seronegativity was detected after booster immunization with either AstV CP truncates in both mice and mink. All mink moms stayed seropositive during the entire 104-day study. Furthermore, lymphoproliferation responses and Th1/Th2 cytokine induction of mice splenocytes ex vivo re-stimulated by truncated CPs were significantly higher than those by CP, with the highest level for CP∆N. Immunization of mink moms with truncated CPs could suppress virus shedding and clinical signs in their litters during a 51-day study after challenge with a heterogeneous MAstV strain. Collectively, AstV truncated CPs exhibit better parameters for protection than full-length CP.

Original languageEnglish (US)
Article number79
JournalVaccines
Volume7
Issue number3
DOIs
StatePublished - Sep 2019

Fingerprint

Mink
Subunit Vaccines
Capsid Proteins
Immunization
Cytokines
Virus Shedding
Secondary Immunization
Amino Acids
Gastroenteritis
Infection
Immune System
Mothers
Antibodies
Serum

Keywords

  • Astrovirus
  • Capsid protein
  • Immunogenicity
  • Infection
  • Subunit vaccine

ASJC Scopus subject areas

  • Immunology
  • Pharmacology
  • Drug Discovery
  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Bidokhti, M. R. M., Ullman, K., Hammer, A. S., Jensen, T. H., Chriél, M., Byrareddy, S. N., & Baule, C. (2019). Immunogenicity and efficacy evaluation of subunit astrovirus vaccines. Vaccines, 7(3), [79]. https://doi.org/10.3390/vaccines7030079

Immunogenicity and efficacy evaluation of subunit astrovirus vaccines. / Bidokhti, Mehdi R.M.; Ullman, Karin; Hammer, Anne Sofie; Jensen, Trine Hammer; Chriél, Mariann; Byrareddy, Siddappa N.; Baule, Claudia.

In: Vaccines, Vol. 7, No. 3, 79, 09.2019.

Research output: Contribution to journalArticle

Bidokhti, MRM, Ullman, K, Hammer, AS, Jensen, TH, Chriél, M, Byrareddy, SN & Baule, C 2019, 'Immunogenicity and efficacy evaluation of subunit astrovirus vaccines', Vaccines, vol. 7, no. 3, 79. https://doi.org/10.3390/vaccines7030079
Bidokhti, Mehdi R.M. ; Ullman, Karin ; Hammer, Anne Sofie ; Jensen, Trine Hammer ; Chriél, Mariann ; Byrareddy, Siddappa N. ; Baule, Claudia. / Immunogenicity and efficacy evaluation of subunit astrovirus vaccines. In: Vaccines. 2019 ; Vol. 7, No. 3.
@article{d9d2dc9cc6494df18ff301bde83de737,
title = "Immunogenicity and efficacy evaluation of subunit astrovirus vaccines",
abstract = "A full understanding of the immune response to astrovirus (AstV) infection is required to treat and control AstV-induced gastroenteritis. Relative contributions of each arm of the immune system in restricting AstV infection remain unknown. In this study, two novel subunit AstV vaccines derived from capsid protein (CP) of mink AstV (MAstV) such as CP∆N (spanning amino acids 161–775) and CP∆C (spanning amino acids 1–621) were evaluated. Their immunogenicity and cytokine production in mice, as well as protective efficacy in mink litters via maternal immunization, were studied. Truncated CPs induced higher levels of serum anti-CP antibodies than CP, with the highest level for CP∆N. No seronegativity was detected after booster immunization with either AstV CP truncates in both mice and mink. All mink moms stayed seropositive during the entire 104-day study. Furthermore, lymphoproliferation responses and Th1/Th2 cytokine induction of mice splenocytes ex vivo re-stimulated by truncated CPs were significantly higher than those by CP, with the highest level for CP∆N. Immunization of mink moms with truncated CPs could suppress virus shedding and clinical signs in their litters during a 51-day study after challenge with a heterogeneous MAstV strain. Collectively, AstV truncated CPs exhibit better parameters for protection than full-length CP.",
keywords = "Astrovirus, Capsid protein, Immunogenicity, Infection, Subunit vaccine",
author = "Bidokhti, {Mehdi R.M.} and Karin Ullman and Hammer, {Anne Sofie} and Jensen, {Trine Hammer} and Mariann Chri{\'e}l and Byrareddy, {Siddappa N.} and Claudia Baule",
year = "2019",
month = "9",
doi = "10.3390/vaccines7030079",
language = "English (US)",
volume = "7",
journal = "Vaccines",
issn = "2076-393X",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",

}

TY - JOUR

T1 - Immunogenicity and efficacy evaluation of subunit astrovirus vaccines

AU - Bidokhti, Mehdi R.M.

AU - Ullman, Karin

AU - Hammer, Anne Sofie

AU - Jensen, Trine Hammer

AU - Chriél, Mariann

AU - Byrareddy, Siddappa N.

AU - Baule, Claudia

PY - 2019/9

Y1 - 2019/9

N2 - A full understanding of the immune response to astrovirus (AstV) infection is required to treat and control AstV-induced gastroenteritis. Relative contributions of each arm of the immune system in restricting AstV infection remain unknown. In this study, two novel subunit AstV vaccines derived from capsid protein (CP) of mink AstV (MAstV) such as CP∆N (spanning amino acids 161–775) and CP∆C (spanning amino acids 1–621) were evaluated. Their immunogenicity and cytokine production in mice, as well as protective efficacy in mink litters via maternal immunization, were studied. Truncated CPs induced higher levels of serum anti-CP antibodies than CP, with the highest level for CP∆N. No seronegativity was detected after booster immunization with either AstV CP truncates in both mice and mink. All mink moms stayed seropositive during the entire 104-day study. Furthermore, lymphoproliferation responses and Th1/Th2 cytokine induction of mice splenocytes ex vivo re-stimulated by truncated CPs were significantly higher than those by CP, with the highest level for CP∆N. Immunization of mink moms with truncated CPs could suppress virus shedding and clinical signs in their litters during a 51-day study after challenge with a heterogeneous MAstV strain. Collectively, AstV truncated CPs exhibit better parameters for protection than full-length CP.

AB - A full understanding of the immune response to astrovirus (AstV) infection is required to treat and control AstV-induced gastroenteritis. Relative contributions of each arm of the immune system in restricting AstV infection remain unknown. In this study, two novel subunit AstV vaccines derived from capsid protein (CP) of mink AstV (MAstV) such as CP∆N (spanning amino acids 161–775) and CP∆C (spanning amino acids 1–621) were evaluated. Their immunogenicity and cytokine production in mice, as well as protective efficacy in mink litters via maternal immunization, were studied. Truncated CPs induced higher levels of serum anti-CP antibodies than CP, with the highest level for CP∆N. No seronegativity was detected after booster immunization with either AstV CP truncates in both mice and mink. All mink moms stayed seropositive during the entire 104-day study. Furthermore, lymphoproliferation responses and Th1/Th2 cytokine induction of mice splenocytes ex vivo re-stimulated by truncated CPs were significantly higher than those by CP, with the highest level for CP∆N. Immunization of mink moms with truncated CPs could suppress virus shedding and clinical signs in their litters during a 51-day study after challenge with a heterogeneous MAstV strain. Collectively, AstV truncated CPs exhibit better parameters for protection than full-length CP.

KW - Astrovirus

KW - Capsid protein

KW - Immunogenicity

KW - Infection

KW - Subunit vaccine

UR - http://www.scopus.com/inward/record.url?scp=85070835002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070835002&partnerID=8YFLogxK

U2 - 10.3390/vaccines7030079

DO - 10.3390/vaccines7030079

M3 - Article

C2 - 31382451

AN - SCOPUS:85070835002

VL - 7

JO - Vaccines

JF - Vaccines

SN - 2076-393X

IS - 3

M1 - 79

ER -